Citations (70)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Elena Guerini, Simone Schadt, Gerard Greig, Ruth Haas, Christophe Husser, Manfred Zell, Christoph Funk, Thomas Hartung, Andreas Gloge & Navita L. Mallalieu. (2017) A double-tracer technique to characterize absorption, distribution, metabolism and excretion (ADME) of [14C]-basimglurant and absolute bioavailability after oral administration and concomitant intravenous microdose administration of [13C6]-labeled basimglurant in humans. Xenobiotica 47:2, pages 144-153.
Read now
Read now
Nicolas Hohmann, Walter E. Haefeli & Gerd Mikus. (2016) CYP3A activity: towards dose adaptation to the individual. Expert Opinion on Drug Metabolism & Toxicology 12:5, pages 479-497.
Read now
Read now
Graham Lappin, Robert Noveck & Tal Burt. (2013) Microdosing and drug development: past, present and future. Expert Opinion on Drug Metabolism & Toxicology 9:7, pages 817-834.
Read now
Read now
Angus N.R. Nedderman, Gordon J. Dear, Stephanie North, R. Scott Obach & David Higton. (2011) From definition to implementation: a cross-industry perspective of past, current and future MIST strategies. Xenobiotica 41:8, pages 605-622.
Read now
Read now
Anil S Modak. (2009) 13C breath tests in personalized medicine: fiction or reality?. Expert Review of Molecular Diagnostics 9:8, pages 805-815.
Read now
Read now
Graham Lappin & R Colin Garner. (2008) The utility of microdosing over the past 5 years. Expert Opinion on Drug Metabolism & Toxicology 4:12, pages 1499-1506.
Read now
Read now
Graham Lappin & Lloyd Stevens. (2008) Biomedical accelerator mass spectrometry: recent applications in metabolism and pharmacokinetics. Expert Opinion on Drug Metabolism & Toxicology 4:8, pages 1021-1033.
Read now
Read now
Thomas Walle, Xia Wen & U Kristina Walle. (2007) Improving metabolic stability of cancer chemoprotective polyphenols. Expert Opinion on Drug Metabolism & Toxicology 3:3, pages 379-388.
Read now
Read now
Articles from other publishers (62)
Suman Chakraborty, Jonathan Gershenzon & Stefan Schuster. (2023) Comparing two strategies of counter-defense against plant toxins: a modeling study on plant–herbivore interactions. Frontiers in Ecology and Evolution 11.
Crossref
Crossref
Anjaneya Chimalakonda, Wenying Li, David Marchisin, Bing He, Shalabh Singhal, Prashant Deshpande, Jonathan Brown, Urvi Aras & Bindu Murthy. (2023) Absolute and Relative Bioavailability of Oral Solid Dosage Formulations of Deucravacitinib in Humans. Clinical Pharmacology in Drug Development.
Crossref
Crossref
Eun Ji Ha, Jeong In Seo, Shaheed Ur Rehman, Hyung Soon Park, Sang-Ku Yoo & Hye Hyun Yoo. (2023) Preclinical Bioavailability Assessment of a Poorly Water-Soluble Drug, HGR4113, Using a Stable Isotope Tracer. Pharmaceutics 15:6, pages 1684.
Crossref
Crossref
Sungah Kim, Joo Ho Lee, Jamie Jarusiewicz, Jen‐Chieh Wang & Kyung Woon Jung. (2022) Hydrogen‐Deuterium Isotope Exchange of Methane via Non‐redox Palladium Catalysis. European Journal of Inorganic Chemistry 26:6.
Crossref
Crossref
R. Lock, P. J. H. Webborn, C. W. Vose & R. M. J. Ings. 2023. The Handbook of Medicinal Chemistry. The Handbook of Medicinal Chemistry
265
297
.
Joseph P. O'Shea, Patrick Augustijns, Martin Brandl, David J. Brayden, Joachim Brouwers, Brendan T. Griffin, René Holm, Ann-Christin Jacobsen, Hans Lennernäs, Zahari Vinarov & Caitriona M. O'Driscoll. (2022) Best practices in current models mimicking drug permeability in the gastrointestinal tract - An UNGAP review. European Journal of Pharmaceutical Sciences 170, pages 106098.
Crossref
Crossref
Stine Overvad Fredslund, Niels Henrik Buus, Cecilie Højgaard Skjold, Esben Laugesen, Anders Bonde Jensen & Britt Elmedal Laursen. (2021) Changes in vascular function during breast cancer treatment. British Journal of Clinical Pharmacology 87:11, pages 4230-4240.
Crossref
Crossref
Axel Treu, Julia Kokesch-Himmelreich, Kerstin Walter, Christoph Hölscher & Andreas Römpp. (2020) Integrating High-Resolution MALDI Imaging into the Development Pipeline of Anti-Tuberculosis Drugs. Journal of the American Society for Mass Spectrometry 31:11, pages 2277-2286.
Crossref
Crossref
H. Markus Weiss, Ken-Ichi Umehara, Veit J. Erpenbeck, Meredith Cain, Janardhana Vemula, Walid Elbast & Markus Zollinger. (2020) A Study of the Effect of Cyclosporine on Fevipiprant Pharmacokinetics and its Absolute Bioavailability Using an Intravenous Microdose Approach. Drug Metabolism and Disposition 48:10, pages 917-924.
Crossref
Crossref
Jeroen Roosendaal, Stefanie L. Groenland, Hilde Rosing, Luc Lucas, Nikkie Venekamp, Bastiaan Nuijen, Alwin D. R. Huitema, Jos H. Beijnen & Neeltje Steeghs. (2020) Determination of the absolute bioavailability of oral imatinib using a stable isotopically labeled intravenous imatinib-d8 microdose. European Journal of Clinical Pharmacology 76:8, pages 1075-1082.
Crossref
Crossref
Jeroen Roosendaal, Hilde Rosing & Jos H. Beijnen. (2020) Stable Isotopically Labeled Intravenous Microdose Pharmacokinetic Trials as a Tool to Assess Absolute Bioavailability: Feasibility and Paradigm to Apply for Protein Kinase Inhibitors in Oncology. Clinical Pharmacology in Drug Development 9:5, pages 552-559.
Crossref
Crossref
Jeroen Roosendaal, Hilde Rosing & Jos H. Beijnen. (2020) Combining Isotopic Tracer Techniques to Increase Efficiency of Clinical Pharmacokinetic Trials in Oncology. Drugs in R&D 20:2, pages 147-154.
Crossref
Crossref
Andrew McEwen. 2020. Drug Discovery and Evaluation: Methods in Clinical Pharmacology. Drug Discovery and Evaluation: Methods in Clinical Pharmacology
773
806
.
Yonghyun Nam, Myungjun Kim, Hang-Seok Chang & Hyunjung Shin. (2019) Drug repurposing with network reinforcement. BMC Bioinformatics 20:S13.
Crossref
Crossref
Todd R Young & Erik M Boczko. (2018) Early treatment gains for antibiotic administration and within human host time series data. Mathematical Medicine and Biology: A Journal of the IMA 35:2, pages 203-224.
Crossref
Crossref
Jens Atzrodt, Volker Derdau, William J. Kerr & Marc Reid. (2018) Deuterium‐ and Tritium‐Labelled Compounds: Applications in the Life Sciences. Angewandte Chemie International Edition 57:7, pages 1758-1784.
Crossref
Crossref
Jens Atzrodt, Volker Derdau, William J. Kerr & Marc Reid. (2018) Deuterium‐ und tritiummarkierte Verbindungen: Anwendungen in den modernen Biowissenschaften. Angewandte Chemie 130:7, pages 1774-1802.
Crossref
Crossref
L. van Andel, H. Rosing, Z. Zhang, L. Hughes, V. Kansra, M. Sanghvi, M. M. Tibben, A. Gebretensae, J. H. M. Schellens & J. H. Beijnen. (2017) Determination of the absolute oral bioavailability of niraparib by simultaneous administration of a 14C-microtracer and therapeutic dose in cancer patients. Cancer Chemotherapy and Pharmacology 81:1, pages 39-46.
Crossref
Crossref
Hao Jiang, Craig Titsch, Jianing Zeng, Barry Jones, Philip Joyce, Yash Gandhi, Wesley Turley, Richard Burrell, Anne F. Aubry & Mark E. Arnold. (2017) Overcoming interference with the detection of a stable isotopically labeled microtracer in the evaluation of beclabuvir absolute bioavailability using a concomitant microtracer approach. Journal of Pharmaceutical and Biomedical Analysis 143, pages 9-16.
Crossref
Crossref
Andrew McEwen. 2017. Drug Discovery and Evaluation: Methods in Clinical Pharmacology. Drug Discovery and Evaluation: Methods in Clinical Pharmacology
1
34
.
Heather A. Enright, Michael A. Malfatti, Maike Zimmermann, Ted Ognibene, Paul Henderson & Kenneth W. Turteltaub. (2016) Use of Accelerator Mass Spectrometry in Human Health and Molecular Toxicology. Chemical Research in Toxicology 29:12, pages 1976-1986.
Crossref
Crossref
Liyang Xie, Sang Gil Lee, Terrence M. Vance, Ying Wang, Bohkyung Kim, Ji-Young Lee, Ock K. Chun & Bradley W. Bolling. (2016) Bioavailability of anthocyanins and colonic polyphenol metabolites following consumption of aronia berry extract. Food Chemistry 211, pages 860-868.
Crossref
Crossref
Gordon J. Dear & Andrew McEwen. 2016. Metabolite Safety in Drug Development. Metabolite Safety in Drug Development
45
85
.
Michael J. Hickey, Paul H. Allen, Lee P. Kingston & David J. Wilkinson. (2016)
The synthesis of [
14
C]AZD5122. Incorporation of an IV
14
C‐microtracer dose into a first in human study to determine the absolute oral bioavailability of AZD5122
. Journal of Labelled Compounds and Radiopharmaceuticals 59:6, pages 245-249.
Crossref
Crossref
Ellen A. Cannady, Aktham Aburub, Chris Ward, Chris Hinds, Boris Czeskis, Kenneth Ruterbories, Jeffrey G. Suico, Jane Royalty, Demetrio Ortega, Brian W. Pack, Syeda L. Begum, William F. Annes, Qun Lin & David S. Small. (2015)
Absolute bioavailability of evacetrapib in healthy subjects determined by simultaneous administration of oral evacetrapib and intravenous [
13
C
8
]‐evacetrapib as a tracer
. Journal of Labelled Compounds and Radiopharmaceuticals 59:6, pages 238-244.
Crossref
Crossref
Mark Kaschwich, Ulf Lützen, Yi Zhao, Angelina Tjiong, Marlies Marx, Sierk Haenisch, Oliver Wiedow, Stefanie Preuss, Juraj Culman & Maaz Zuhayra. (2016) Biodistribution and pharmacokinetics of the 99mTc labeled human elastase inhibitor, elafin, in rats. Drug Metabolism and Pharmacokinetics 31:2, pages 146-155.
Crossref
Crossref
Graham Lappin. (2016) Approaches to intravenous clinical pharmacokinetics: Recent developments with isotopic microtracers. The Journal of Clinical Pharmacology 56:1, pages 11-23.
Crossref
Crossref
Tjerk Bueters, Christopher Gibson & Sandra A G Visser. (2015) Optimization of human dose prediction by using quantitative and translational pharmacology in drug discovery. Future Medicinal Chemistry 7:17, pages 2351-2369.
Crossref
Crossref
Colin R. Garner, Kevin B. Park, Neil S. French, Caroline Earnshaw, Alessandro Schipani, Andrew M. Selby, Lindsay Byrne, Sarah Siner, Francis P. Crawley, Wouter H. J. Vaes, Esther van Duijn, Rianne deLigt, Heili Varendi, Jane Lass, Grzegorz Grynkiewicz, Wioletta Maruszak & Mark A. Turner. (2015)
Observational infant exploratory [
14
C]-paracetamol pharmacokinetic microdose/therapeutic dose study with accelerator mass spectrometry bioanalysis
. British Journal of Clinical Pharmacology 80:1, pages 157-167.
Crossref
Crossref
Graeme C Young & Mark Seymour. (2015)
Application of
14
C-Accelerator MS in pharmaceutical development
. Bioanalysis 7:5, pages 513-517.
Crossref
Crossref
William F. Annes, Amanda Long, Jennifer W. Witcher, Mosun A. Ayan-Oshodi, Mary Pat Knadler, Wei Zhang, Malcolm I. Mitchell, Karen Cornelissen & Stephen D. Hall. (2015) Relative Contributions of Presystemic and Systemic Peptidases to Oral Exposure of a Novel Metabotropic Glutamate 2/3 Receptor Agonist (LY404039) After Oral Administration of Prodrug Pomaglumetad Methionil (LY2140023). Journal of Pharmaceutical Sciences 104:1, pages 207-214.
Crossref
Crossref
R. Colin Garner. 2014. Human-based Systems for Translational Research. Human-based Systems for Translational Research
241
266
.
Jens Atzrodt & Volker Derdau. (2013) Selected Scientific Topics of the 11th International Isotope Symposium on the Synthesis and Applications of Isotopes and Isotopically Labeled Compounds. Journal of Labelled Compounds and Radiopharmaceuticals 56:9-10, pages 408-416.
Crossref
Crossref
Dietmar Schwab, Agnes Portron, Zoe Backholer, Berthold Lausecker & Kosuke Kawashima. (2013) A Novel Double-Tracer Technique to Characterize Absorption, Distribution, Metabolism and Excretion (ADME) of [14C]Tofogliflozin After Oral Administration and Concomitant Intravenous Microdose Administration of [13C]Tofogliflozin in Humans. Clinical Pharmacokinetics 52:6, pages 463-473.
Crossref
Crossref
Alan Parr, Manish Gupta, Timothy H Montague & Frank Hoke. (2012) Re-introduction of a Novel Approach to the Use of Stable Isotopes in Pharmacokinetic Studies. The AAPS Journal 14:3, pages 639-645.
Crossref
Crossref
Huidong Gu, Jian Wang, Anne-Françoise Aubry, Hao Jiang, Jianing Zeng, John Easter, Jun-sheng Wang, Randy Dockens, Marc Bifano, Richard Burrell & Mark E. Arnold. (2012) Calculation and Mitigation of Isotopic Interferences in Liquid Chromatography–Mass Spectrometry/Mass Spectrometry Assays and Its Application in Supporting Microdose Absolute Bioavailability Studies. Analytical Chemistry 84:11, pages 4844-4850.
Crossref
Crossref
Xiaomin Wang, Voon Ong & Mark Seymour. 2012. ADME‐Enabling Technologies in Drug Design and Development. ADME‐Enabling Technologies in Drug Design and Development
331
338
.
Alexander V. LyubimovBenny M. Amore. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
39
.
Arthur J. AtkinsonJr.Jr.. 2012. Principles of Clinical Pharmacology. Principles of Clinical Pharmacology
41
53
.
Mark A Seymour. (2011) Accelerator MS: its role as a frontline bioanalytical technique. Bioanalysis 3:24, pages 2817-2823.
Crossref
Crossref
Yi-ming LIU, Ying-chun LIU, Huan-zhong DING, Bing-hu FANG, Fan YANG, Qi SHAN & Zhen-ling ZENG. (2011) Pharmacokinetics of Mequindox and Its Metabolites in Swine. Agricultural Sciences in China 10:12, pages 1968-1976.
Crossref
Crossref
Lan Gao, Jing Li, Claudia Kasserra, Qi Song, Ali Arjomand, David Hesk & Swapan K Chowdhury. (2011) Precision and Accuracy in the Quantitative Analysis of Biological Samples by Accelerator Mass Spectrometry: Application in Microdose Absolute Bioavailability Studies. Analytical Chemistry 83:14, pages 5607-5616.
Crossref
Crossref
Graham Lappin, Yoko Shishikura, Roeline Jochemsen, Richard John Weaver, Charlotte Gesson, J. Brian Houston, Berend Oosterhuis, Ole J. Bjerrum, Grzegorz Grynkiewicz, Jane Alder, Malcolm Rowland & Colin Garner. (2011) Comparative pharmacokinetics between a microdose and therapeutic dose for clarithromycin, sumatriptan, propafenone, paracetamol (acetaminophen), and phenobarbital in human volunteers. European Journal of Pharmaceutical Sciences 43:3, pages 141-150.
Crossref
Crossref
Stephen R. Dueker, Le T. Vuong, Peter N. Lohstroh, Jason A. Giacomo & John S. Vogel. (2011) Quantifying exploratory low dose compounds in humans with AMS. Advanced Drug Delivery Reviews 63:7, pages 518-531.
Crossref
Crossref
Guy C. Lloyd‐Jones & Sophie Purser. (2011)
A Metathesis Approach to Volatile Olefins: Synthesis of
18
O‐Allyl Alcohol
. Chemistry – A European Journal 17:17, pages 4724-4726.
Crossref
Crossref
Graham Lappin, Mark Seymour, Graeme Young, David Higton & Howard M Hill. (2011) An AMS method to determine analyte recovery from pharmacokinetic studies with concomitant extravascular and intravenous administration. Bioanalysis 3:4, pages 407-410.
Crossref
Crossref
Graham Lappin, Mark Seymour, Graeme Young, David Higton & Howard M Hill. (2011) AMS method validation for quantitation in pharmacokinetic studies with concomitant extravascular and intravenous administration. Bioanalysis 3:4, pages 393-405.
Crossref
Crossref
Claudia C. Wagner, Marie Simpson, Markus Zeitlinger, Martin Bauer, Rudolf Karch, Aiman Abrahim, Thomas Feurstein, Matthias Schütz, Kurt Kletter, Markus Müller, Graham Lappin & Oliver Langer. (2011) A Combined Accelerator Mass Spectrometry-Positron Emission Tomography Human Microdose Study with 14C- and 11C-Labelled Verapamil. Clinical Pharmacokinetics 50:2, pages 111-120.
Crossref
Crossref
Graham Lappin. 2011. Pharmacokinetics in Drug Development. Pharmacokinetics in Drug Development
115
130
.
Kuresh A. Youdim & Kenneth C. Saunders. (2010) A review of LC–MS techniques and high-throughput approaches used to investigate drug metabolism by cytochrome P450s. Journal of Chromatography B 878:17-18, pages 1326-1336.
Crossref
Crossref
Graham Lappin, Yoko Shishikura, Roeline Jochemsen, Richard John Weaver, Charlotte Gesson, Brian Houston, Berend Oosterhuis, Ole J. Bjerrum, Malcolm Rowland & Colin Garner. (2010) Pharmacokinetics of fexofenadine: Evaluation of a microdose and assessment of absolute oral bioavailability. European Journal of Pharmaceutical Sciences 40:2, pages 125-131.
Crossref
Crossref
Stephen R DuekerPeter N LohstrohJason A GiacomoLe T VuongBradly D KeckJohn S Vogel. (2010) Early human ADME using microdoses and microtracers: bioanalytical considerations. Bioanalysis 2:3, pages 441-454.
Crossref
Crossref
Ali Arjomand. (2010) Accelerator mass spectrometry-enabled studies: current status and future prospects. Bioanalysis 2:3, pages 519-541.
Crossref
Crossref
Anil S Modak. (2010) Single time point diagnostic breath tests: a review. Journal of Breath Research 4:1, pages 017002.
Crossref
Crossref
Lan Gao & Swapan Chowdhury. 2009. Using Mass Spectrometry for Drug Metabolism Studies, Second Edition. Using Mass Spectrometry for Drug Metabolism Studies, Second Edition
391
418
.
Yoshihiro Miyaji, Tomoko Ishizuka, Kenji Kawai, Yoshimi Hamabe, Teiji Miyaoka, Toshinari Oh-hara, Toshihiko Ikeda & Atsushi Kurihara. (2009) Use of An Intravenous Microdose of 14C-labeled drug and Accelerator Mass Spectrometry to measure Absolute Oral Bioavailability in Dogs; Cross-comparison of Assay Methods by Accelerator Mass Spectrometry and Liquid Chromatography-Tandem Mass Spectrometry. Drug Metabolism and Pharmacokinetics 24:2, pages 130-138.
Crossref
Crossref
Thomas N. Thompson. 2009. Annual Reports in Medicinal Chemistry Volume 44. Annual Reports in Medicinal Chemistry Volume 44
459
474
.
Wing W. Lam, Cho‐Ming Loi, Angus Nedderman & Don Walker. 2008. Mass Spectrometry in Drug Metabolism and Pharmacokinetics. Mass Spectrometry in Drug Metabolism and Pharmacokinetics
253
273
.
Ayman El‐Kattan, Chris Holliman & Lucinda H. Cohen. 2008. Mass Spectrometry in Drug Metabolism and Pharmacokinetics. Mass Spectrometry in Drug Metabolism and Pharmacokinetics
87
121
.
G. Lappin, M. Simpson, Y. Shishikura & C. Garner. (2008) High-performance liquid chromatography accelerator mass spectrometry: Correcting for losses during analysis by internal standardization. Analytical Biochemistry 378:1, pages 93-95.
Crossref
Crossref
Martin Bauer, Claudia Christina Wagner & Oliver Langer. (2008) Microdosing Studies in Humans. Drugs in R & D 9:2, pages 73-81.
Crossref
Crossref
Alex Sparreboom. (2007) Unexplored Pharmacokinetic Opportunities with Microdosing in Oncology. Clinical Cancer Research 13:14, pages 4033-4034.
Crossref
Crossref